Leading lab diagnostics providers in Russia 2022

Invitro was the leading laboratory diagnostics provider in Russia, having occupied a market share of 8.6 percent as of 2022. Gemotest and KDL ranked second and third, respectively, with 7.1 percent, and 4.7 percent, respectively.

Invitro（细胞试验）自2022年起一直位居俄罗斯实验室诊断领域的龙头地位，市场份额高达8.6%。Gemotest（基因测试）与KDL（康德乐）依次位居第二、第三，市场份额分别为7.1%和4.7%。